Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival.
We present a 5-year survivor with lung adenocarcinoma accompanied by carcinomatous pleuritis who underwent pleuropneumonectomy followed by systemic chemotherapy. The pleural disease was not detectable on the chest roentgenograms or computed tomographic scans. The combination of the surgical procedure and postoperative adjuvant chemotherapy may be a potentially curative treatment in selected patients with carcinomatous pleuritis of lung cancer.
Yokoi
K
K
Division of Thoracic Surgery, Tochigi Cancer Center, Japan.
Miyazawa
N
N
D000231:Adenocarcinoma, Papillary / Q000188:drug therapy / Q000556:secondary / Q000601:surgery*; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000601:surgery*; D008207:Lymphatic Metastasis; D010994:Pleura / Q000601:surgery*; D016066:Pleural Effusion, Malignant / Q000601:surgery; D010997:Pleural Neoplasms / Q000188:drug therapy / Q000601:surgery*; D010998:Pleurisy / Q000188:drug therapy / Q000601:surgery*; D011013:Pneumonectomy; D015996:Survival Rate; D014751:Vindesine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D002945:Cisplatin; D014751:Vindesine